We serve Chemical Name:7-bromo-2-methylindazole-3-carboxylic acid CAS:701910-30-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:7-bromo-2-methylindazole-3-carboxylic acid
CAS.NO:701910-30-7
Synonyms:7-Bromo-2-methyl-2H-indazole-3-carboxylic acid;7-bromo-2-methyl-2H-indazole-3-carboxylic acide
Molecular Formula:C9H7BrN2O2
Molecular Weight:255.06800
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:468.4ºC at 760 mmHg
Density:1.79g/cm3
Index of Refraction:1.7
PSA:55.12000
Exact Mass:253.96900
LogP:2.03400
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 7-Bromo-2-methyl-2H-indazole-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-bromo-2-methyl-2H-indazole-3-carboxylic acide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-bromo-2-methyl-2H-indazole-3-carboxylic acide Use and application,7-bromo-2-methyl-2H-indazole-3-carboxylic acide technical grade,usp/ep/jp grade.
Related News: Over the past two to three years, VBP has become “quite a challenge,” AZ’s international and China market chief Leon Wang said on the call. In response, the company has resorted to multichannel marketing, turning to the retail pharmacy market to soften the blow of tender losses. 2,6-di-tert-butylphenyl (1S,2S)-2-phenylcyclopropane-1-carboxylate manufacturers “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement. 2-nitro-4-(2-nitrophenoxy)aniline suppliers About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. Pyrazoloacridine vendor & factory.
